Ondansetron Tablet, Orally Disintegrating
Product Images NDC 68071-3926

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 68071-3926). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3926 3)

Label for Ondansetron ODT 8 mg orally disintegrating tablets by NuCare Pharmaceuticals, Inc. The label indicates a package of 30 tablets with the product number R1237030. It includes a red NuCare Pharmaceuticals logo and instructions to see the manufacturer's label for full ingredients. Storage instructions specify controlled temperature 68-77°F, with warnings to keep out of reach of children.*

FDA Label Image

Logo (Logo)

FDA Label Image

Structure-base (Structure Base)

Chemical structure of ondansetron, depicting its fused ring system with a ketone group and a methyl-substituted imidazole ring.*

FDA Label Image

Structure-hcl (Structure HCl)

Chemical structure of Ondansetron hydrochloride dihydrate, showing its molecular configuration including an indole ring system and imidazole moiety with associated hydrochloride and water molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.